Related references
Note: Only part of the references are listed.The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models
Slavka Lukacova et al.
ACTA ONCOLOGICA (2008)
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors
Amy Moreno et al.
ENDOCRINE-RELATED CANCER (2008)
Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors
Do Ha Kim et al.
GENES CHROMOSOMES & CANCER (2008)
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients
Mizutomo Azuma et al.
PHARMACOGENOMICS (2007)
TNM staging of midgut and hindgut (neuro) endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2007)
Regarding adjuvant radiation therapy in Merkel cell carcinoma: Selection bias and its affect on overall survival - In reply
Pablo Mojica et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)
In-Seon Choi et al.
MODERN PATHOLOGY (2007)
Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors
Eric H. Jensen et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Clinical and in vitro studies of imatinib in advanced carcinoid tumors
James C. Yao et al.
CLINICAL CANCER RESEARCH (2007)
Antianglogenic potential of the mammalian target of rapamycin inhibitor temsirolimus
Donatella Del Bufalo et al.
CANCER RESEARCH (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
MH Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors
GG Wang et al.
MODERN PATHOLOGY (2005)
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors
MH Shah et al.
CLINICAL CANCER RESEARCH (2004)
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas
MA Kouvaraki et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
